| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/15/2004 | US6749858 Nucleotide sequences coding polypeptide for use in the prevention of streptoccocus infection |
| 06/15/2004 | US6749857 Recombinant dimeric envelope vaccine against flaviviral infection |
| 06/15/2004 | US6749854 Use of OX-2 to inhibit fetal loss |
| 06/15/2004 | US6749847 Chemokine for use in of tumors |
| 06/15/2004 | US6748900 Methods for growing and imprinting fish using an odorant |
| 06/15/2004 | CA2285921C Composition and method for treatment of cmv infections |
| 06/15/2004 | CA2049921C Allergenic proteins from ragweed and uses therefor |
| 06/10/2004 | WO2004053123A1 METHOD OF EFFICIENTLY RECOMBINING ORF ENCODED BY cDNA AND TEMPLATE VECTOR, TRAP VECTOR AND PRIMER TO BE USED THEREIN |
| 06/10/2004 | WO2004049234A1 Method of identifying disease-sensitivity gene and program and system to be used therefor |
| 06/10/2004 | WO2004048974A1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 06/10/2004 | WO2004048925A2 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
| 06/10/2004 | WO2004048606A2 Porcine polymorphisms and methods for detecting them |
| 06/10/2004 | WO2004048604A1 Method of screening compound inhibiting enzymatic activity of gwt1 gene product |
| 06/10/2004 | WO2004048601A2 Modulation of b7h expression |
| 06/10/2004 | WO2004048595A2 Vascular-preferred promoters |
| 06/10/2004 | WO2004048584A1 Sequence specific dna recombination in eukaryotic cells |
| 06/10/2004 | WO2004048583A2 Compositions and systems for the regulation of genes |
| 06/10/2004 | WO2004048582A2 Recombinant poxvirus comprising at least two cowpox ati promoters |
| 06/10/2004 | WO2004048581A1 Method for expressing inducible rnai in cells, nucleic acid molecules therefor and cells transformed by said molecules |
| 06/10/2004 | WO2004048580A1 A method for marker-less integration of a sequence of interest into the genome of a cell |
| 06/10/2004 | WO2004048579A1 A role in lignification and growth for plant phenylcoumaran benzylic ether reductase |
| 06/10/2004 | WO2004048578A1 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 06/10/2004 | WO2004048577A1 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer |
| 06/10/2004 | WO2004048576A1 Phosphorylated ndr kinase |
| 06/10/2004 | WO2004048575A2 Streptococcus pneumoniae surface polypeptides |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048573A1 Mammalian prickle gene |
| 06/10/2004 | WO2004048572A1 Type 2 diabetes-associated gene |
| 06/10/2004 | WO2004048571A1 Antibody against lesion tissue |
| 06/10/2004 | WO2004048570A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
| 06/10/2004 | WO2004048568A1 UTILIZATION OF mKank GENE IN CANTER THERAPY, CANER DETECTION AND DRUG DISCOVERY |
| 06/10/2004 | WO2004048566A1 Method of detecting target base sequence of rna interference, method of designing polynucleotide base sequence causing rna interference, method of constructing double-stranded polynucleotide, method of regulating gene expression, base sequence processing apparatus, program for running base sequence processing method on comp |
| 06/10/2004 | WO2004048564A1 Device for pretreating specimen |
| 06/10/2004 | WO2004048563A1 Dna polymerase isolated from aeropyrum pernix and its preparation method |
| 06/10/2004 | WO2004048562A1 PROCESSES FOR PRODUCING HUMAN-ORIGIN β1,3-N-ACETYLGLUCOSAMINYL TRANSFERASE 2 |
| 06/10/2004 | WO2004048558A2 Heparanase mediated cell adhesion and uses thereof |
| 06/10/2004 | WO2004048555A1 Restoration of methylation states in cells |
| 06/10/2004 | WO2004048554A1 Cell extract of escherichia coli having mutation in s12 ribosomal protein and process for producing protein in cell-free system using the same |
| 06/10/2004 | WO2004048545A2 DELIVERY OF siRNAs______________________________________________ |
| 06/10/2004 | WO2004048543A2 Methods and compositions for controlling valency of phage display |
| 06/10/2004 | WO2004048535A2 Sugar and lipid metabolism regulators in plants v |
| 06/10/2004 | WO2004048534A2 Modulation of cytokine-inducible kinase expression |
| 06/10/2004 | WO2004048533A2 Modulation of forkhead box c2 expression |
| 06/10/2004 | WO2004048526A2 MODULATION OF HIF1α AND HIF2α EXPRESSION |
| 06/10/2004 | WO2004048523A2 Modulation of ku86 expression |
| 06/10/2004 | WO2004048522A2 Modulation of huntingtin interacting protein 2 expression |
| 06/10/2004 | WO2004048519A2 Treatment of mammalian reaction to ige interactions |
| 06/10/2004 | WO2004048515A2 Streptococcus uberis adhesion molecule |
| 06/10/2004 | WO2004048514A2 Methods for analyzing a nucleic acid |
| 06/10/2004 | WO2004048512A2 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | WO2004048511A2 Bioinformatically detectable group of novel viral regulatory genes and uses thereof |
| 06/10/2004 | WO2004048410A2 T-cell receptors |
| 06/10/2004 | WO2004048406A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/10/2004 | WO2004048403A2 Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element |
| 06/10/2004 | WO2004048402A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 06/10/2004 | WO2004048398A1 Method and apparatus for concentration and purification of nucleic acid |
| 06/10/2004 | WO2004048376A1 Bicyclic naphthylidine nucleosides |
| 06/10/2004 | WO2004048325A2 Modulation of jagged 1 expression |
| 06/10/2004 | WO2004047872A2 Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna) |
| 06/10/2004 | WO2004047853A2 Methods for the treatment of chronic pain and compositions therefor |
| 06/10/2004 | WO2004047812A1 Hollow nanoparticles of protein and drug using the same |
| 06/10/2004 | WO2004047770A2 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 06/10/2004 | WO2004047764A2 Modulation of hiv replication by rna interference |
| 06/10/2004 | WO2004047750A2 Modulation of notch2 expression |
| 06/10/2004 | WO2004047742A2 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 06/10/2004 | WO2004047741A2 Modulation of iap-like expression |
| 06/10/2004 | WO2004047740A2 Composition and method for treating lupus nephritis |
| 06/10/2004 | WO2004047736A2 Modulation of bcl2-associated athanogene expression |
| 06/10/2004 | WO2004047731A2 Modulation of notch3 expression |
| 06/10/2004 | WO2004047728A2 Compositions and methods for the treatment of immune related diseases |
| 06/10/2004 | WO2004047720A2 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 06/10/2004 | WO2004047634A1 Zebrafish assay |
| 06/10/2004 | WO2004047612A2 Methods of therapy and diagnosis |
| 06/10/2004 | WO2004047531A2 Protein production in transgenic avians using lentiviral system |
| 06/10/2004 | WO2004047530A1 Transgenic model expressing a prp gene homozygous for m129 |
| 06/10/2004 | WO2004047522A1 Method of in planta transformation of kenaf plant with agrobacterium tumefaciens |
| 06/10/2004 | WO2004037202A9 Gb virus c and methods of treating viral infections |
| 06/10/2004 | WO2004035799A3 Viral vectors and the use of the same for gene therapy |
| 06/10/2004 | WO2004035010A8 Methods and organisms for production of b6 vitamers |
| 06/10/2004 | WO2004034995A9 Methods and reagents for inducing immunity |
| 06/10/2004 | WO2004033672A3 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 06/10/2004 | WO2004030660A3 Compositions for treatment of prostate and other cancers |
| 06/10/2004 | WO2004029278A3 Aav itr-mediated modulation |
| 06/10/2004 | WO2004029086A3 Regulation of human calcium-independent alpha-latrotoxin receptor homolog 3 |
| 06/10/2004 | WO2004020468A3 Interferon beta-like molecules for treatment of cancer |
| 06/10/2004 | WO2004016793A3 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004011647A8 Modified small interfering rna molecules and methods of use |
| 06/10/2004 | WO2004003189A3 Regulation of human phospholipase c-like protein |
| 06/10/2004 | WO2004000994A3 Novel acetylcholinesterase gene responsible for insecticide resistance and applications thereof |
| 06/10/2004 | WO2003106476A8 Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity |
| 06/10/2004 | WO2003104470A3 Retrons for gene targeting |
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003099224A3 Antisense moodulation of kinesin-like 1 expression |
| 06/10/2004 | WO2003093424A9 In vivo ssdna expression vectors for altering gene expression |
| 06/10/2004 | WO2003089641A3 Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems |
| 06/10/2004 | WO2003089586A3 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
| 06/10/2004 | WO2003089571A3 Ehrlichia canis genes and vaccines |
| 06/10/2004 | WO2003087373A3 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients |
| 06/10/2004 | WO2003087323A3 Biologic modulations with nanoparticles |